AXSM
Axsome Therapeutics, Inc.
Stock
$179.25−2.82 (−1.55%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $571M
- YoY, 2025
- +38.7%
- 5-year CAGR
- +81.6%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $571M | +38.7% |
| 2024 | $411M | +27.3% |
| 2023 | $323M | +102.9% |
| 2022 | $159M | +139.0% |
| 2021 | $67M | +130.6% |
| 2020 | $29M | — |